![Bias was reduced in an open-label trial through the removal of subjective elements from the outcome definition - Journal of Clinical Epidemiology Bias was reduced in an open-label trial through the removal of subjective elements from the outcome definition - Journal of Clinical Epidemiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2080812205/2072208225/gr1.jpg)
Bias was reduced in an open-label trial through the removal of subjective elements from the outcome definition - Journal of Clinical Epidemiology
PLOS ONE: A Randomized Open-Label Trial of Artesunate- Sulfadoxine-Pyrimethamine with or without Primaquine for Elimination of Sub-Microscopic P. falciparum Parasitaemia and Gametocyte Carriage in Eastern Sudan
![An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis | Arthritis Research & Therapy | Full Text An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-019-1857-3/MediaObjects/13075_2019_1857_Fig1_HTML.png)
An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis | Arthritis Research & Therapy | Full Text
PLOS ONE: A Phase I, Open-Label Trial, Evaluating the Safety and Immunogenicity of Candidate Tuberculosis Vaccines AERAS-402 and MVA85A, Administered by Prime-Boost Regime in BCG-Vaccinated Healthy Adults
![Single center, open label dose escalating trial evaluating once weekly oral ixazomib in ART-suppressed, HIV positive adults and effects on HIV reservoir size in vivo - eClinicalMedicine Single center, open label dose escalating trial evaluating once weekly oral ixazomib in ART-suppressed, HIV positive adults and effects on HIV reservoir size in vivo - eClinicalMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/618f5366-326d-4aac-9d85-05c9687bd2d1/gr1_lrg.jpg)
Single center, open label dose escalating trial evaluating once weekly oral ixazomib in ART-suppressed, HIV positive adults and effects on HIV reservoir size in vivo - eClinicalMedicine
![PDF] Bias was reduced in an open-label trial through the removal of subjective elements from the outcome definition. | Semantic Scholar PDF] Bias was reduced in an open-label trial through the removal of subjective elements from the outcome definition. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/814ad6ccbfa9defca4d2b00c4672f9070cf6b8da/16-Figure1-1.png)
PDF] Bias was reduced in an open-label trial through the removal of subjective elements from the outcome definition. | Semantic Scholar
![How to process data from clinical trials and their open label extensions PhUSE, Berlin, October 2010 Thomas Grupe and Stephanie Bartsch, Clinical Data. - ppt download How to process data from clinical trials and their open label extensions PhUSE, Berlin, October 2010 Thomas Grupe and Stephanie Bartsch, Clinical Data. - ppt download](https://images.slideplayer.com/23/6590870/slides/slide_3.jpg)
How to process data from clinical trials and their open label extensions PhUSE, Berlin, October 2010 Thomas Grupe and Stephanie Bartsch, Clinical Data. - ppt download
![Safety and tolerability of adjunctive lacosamide in a pediatric population with focal seizures – An open-label trial - Seizure - European Journal of Epilepsy Safety and tolerability of adjunctive lacosamide in a pediatric population with focal seizures – An open-label trial - Seizure - European Journal of Epilepsy](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f5b9964c-4331-4321-a712-8d6a65155a91/gr1_lrg.jpg)
Safety and tolerability of adjunctive lacosamide in a pediatric population with focal seizures – An open-label trial - Seizure - European Journal of Epilepsy
![Understanding Clinical Trial Terminology: What is an Open Label Clinical Trial? - Concert Pharmaceuticals Understanding Clinical Trial Terminology: What is an Open Label Clinical Trial? - Concert Pharmaceuticals](https://www.concertpharma.com/wp-content/uploads/2019/06/clinicaltrials-2-e1566478031946.jpg)
Understanding Clinical Trial Terminology: What is an Open Label Clinical Trial? - Concert Pharmaceuticals
![ASCO GU 2020: Results from ATLAS, a Phase 2, Open-Label Trial: Rucaparib for Recurrent, Locally Advanced or Metastatic Urothelial Carcinoma ASCO GU 2020: Results from ATLAS, a Phase 2, Open-Label Trial: Rucaparib for Recurrent, Locally Advanced or Metastatic Urothelial Carcinoma](https://www.urotoday.com/images/atlas_trial_schema.png)
ASCO GU 2020: Results from ATLAS, a Phase 2, Open-Label Trial: Rucaparib for Recurrent, Locally Advanced or Metastatic Urothelial Carcinoma
![PDF] Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial | Semantic Scholar PDF] Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/60afa7902fddea770036d6744ee84027545bd238/3-Figure1-1.png)
PDF] Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial | Semantic Scholar
![Headache Journal on Twitter: "Transcranial Magnetic Stimulation for #Migraine Prevention in #Adolescents: A Pilot Open-Label Study #TMS SL Irwin et al @aagelfand @petergoadsby https://t.co/ThCNhNnWbu https://t.co/eummTQHnsY" / Twitter Headache Journal on Twitter: "Transcranial Magnetic Stimulation for #Migraine Prevention in #Adolescents: A Pilot Open-Label Study #TMS SL Irwin et al @aagelfand @petergoadsby https://t.co/ThCNhNnWbu https://t.co/eummTQHnsY" / Twitter](https://pbs.twimg.com/media/DYMn_dNWkAA0P_E.jpg)
Headache Journal on Twitter: "Transcranial Magnetic Stimulation for #Migraine Prevention in #Adolescents: A Pilot Open-Label Study #TMS SL Irwin et al @aagelfand @petergoadsby https://t.co/ThCNhNnWbu https://t.co/eummTQHnsY" / Twitter
![A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism | Genetics in Medicine A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism | Genetics in Medicine](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41436-020-01006-8/MediaObjects/41436_2020_1006_Fig1_HTML.png)
A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism | Genetics in Medicine
![An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19 - Clinical Microbiology and Infection An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19 - Clinical Microbiology and Infection](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/7b2838e8-53f2-4a1b-9a19-5738831c53bd/gr1.jpg)
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19 - Clinical Microbiology and Infection
PIONEER Trial: An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy | tctmd.com
![Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial - The Lancet Neurology Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/e53ef392-4fec-49e2-b653-2896383e183d/gr1.gif)